These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35382979)

  • 21. Human leukocyte antigen-G: immunotolerant major histocompatibility complex molecule in transplantation.
    Khalil-Daher I; Rouas-Freiss N; Carosella ED; Dausset JB
    World J Surg; 2000 Jul; 24(7):819-22. PubMed ID: 10833249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor.
    Morel E; Bellón T
    Allergy; 2007 Feb; 62(2):190-6. PubMed ID: 17298429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA and pregnancy: the paradox of the fetal allograft.
    Ober C
    Am J Hum Genet; 1998 Jan; 62(1):1-5. PubMed ID: 9443885
    [No Abstract]   [Full Text] [Related]  

  • 24. HLA-G: a tolerance molecule from the major histocompatibility complex.
    Carosella ED; Rouas-Freiss N; Paul P; Dausset J
    Immunol Today; 1999 Feb; 20(2):60-2. PubMed ID: 10098322
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells.
    Morales PJ; Pace JL; Platt JS; Langat DK; Hunt JS
    Immunology; 2007 Oct; 122(2):179-88. PubMed ID: 17484767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G.
    Liang S; Horuzsko A
    Hum Immunol; 2003 Nov; 64(11):1025-32. PubMed ID: 14602231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HLA-G: immune tolerance in normal and pathological physiology].
    Le Discorde M; Moreau P; Rouas-Freiss N; Carosella E
    Pathol Biol (Paris); 2002 Feb; 50(1):45-51. PubMed ID: 11873630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenetics of reproduction: an overview.
    Ober C; van der Ven K
    Curr Top Microbiol Immunol; 1997; 222():1-23. PubMed ID: 9257483
    [No Abstract]   [Full Text] [Related]  

  • 29. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.
    Carosella ED; Moreau P; Le Maoult J; Le Discorde M; Dausset J; Rouas-Freiss N
    Adv Immunol; 2003; 81():199-252. PubMed ID: 14711057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HLA-G: fetomaternal tolerance].
    Carosella ED
    C R Acad Sci III; 2000 Aug; 323(8):675-80. PubMed ID: 11019361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New aspects in celiac disease.
    Torres MI; López Casado MA; Ríos A
    World J Gastroenterol; 2007 Feb; 13(8):1156-61. PubMed ID: 17451193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
    Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
    Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-G and inflammatory diseases.
    Baricordi OR; Stignani M; Melchiorri L; Rizzo R
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):67-74. PubMed ID: 18691135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
    Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
    Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Induction of tolerogenic dendritic cells by membrane-bound HLA-G in vitro].
    Zhou H; Li WM; Zhang M; Liu ZR; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):369-72. PubMed ID: 17493349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
    Amiot L; Ferrone S; Grosse-Wilde H; Seliger B
    Cell Mol Life Sci; 2011 Feb; 68(3):417-31. PubMed ID: 21063893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fetomaternal tolerance: role of HLA-G molecule in the protection of the fetus against maternal natural killer activity].
    Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    C R Acad Sci III; 1997 May; 320(5):385-92. PubMed ID: 9239324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrameric complexes of HLA-E, HLA-F, and HLA-G.
    Allan DS; Lepin EJ; Braud VM; O'Callaghan CA; McMichael AJ
    J Immunol Methods; 2002 Oct; 268(1):43-50. PubMed ID: 12213342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerization of dendritic cells by HLA-G.
    Ristich V; Liang S; Zhang W; Wu J; Horuzsko A
    Eur J Immunol; 2005 Apr; 35(4):1133-42. PubMed ID: 15770701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.